Back to results
US 2008/0176851 A1Published application
Method for inhibiting lymphangiogenesis and inflammation
AssigneesShiseido Company, Ltd., ETH Zurich
InventorsKentaro Kajiya, Michael Detmar
Life of this patent
Estimating the term…
Abstract
A method for inhibiting lymphangiogenesis and/or inflammation by blocking sGCα1β1 signaling is provided. In a preferable embodiment, the blockage of sGCα1β1 signaling is accomplished by means of applying sGC inhibitor such as NS-2028 on skin.
Claims3
A method for inhibiting lymphangiogenesis and/or inflammation by blocking sGCα1β1 signaling.
Dependencies are inferred from the claim text.